Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 30.
doi: 10.1245/s10434-025-17743-6. Online ahead of print.

Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments"

Heyue Zhang  1 , Jin Xu  1 , Yinping Jiang  2 , Xudong Zhu  3 , Hailin Tang  4
Affiliations

Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments"

Heyue Zhang et al. Ann Surg Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure: There are no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Kobayashi K, Kishi Y, Tsunenari T, et al. Dissecting tumor size underestimation in pancreatic cancer: a comparative analysis of preoperative treatments. Ann Surg Oncol. 2025;32:3593–602. https://doi.org/10.1245/s10434-025-16917-6 . - DOI - PubMed - PMC
    1. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:439–57. https://doi.org/10.6004/jnccn.2021.0017 . - DOI - PubMed
    1. Uson Junior PLS, Dias ESD, de Castro NM, et al. Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials. ESMO Open. 2023;8:100771. https://doi.org/10.1016/j.esmoop.2022.100771 . - DOI - PubMed - PMC
    1. Ghaneh P, Palmer D, Cicconi S, et al. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8:157–68. https://doi.org/10.1016/S2468-1253(22)00348-X . - DOI - PubMed
    1. He J, Lv N, Yang Z, Luo Y, Zhong W, Wu C. Comparing upfront surgery with neoadjuvant treatments in patients with resectable, borderline resectable, or locally advanced pancreatic cancer: a systematic review and network meta-analysis of randomized clinical trials. Int J Surg. 2024;110:3900–9. https://doi.org/10.1097/JS9.0000000000001313 . - DOI - PubMed - PMC

LinkOut - more resources